The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Severe Vasculitis After Therapy With Diazepam

Published Online:https://doi.org/10.1176/ajp.156.6.972a

To the Editor: Diazepam is a benzodiazepine prescribed worldwide. In respect to its posology and indications, the drug is generally well tolerated. Hypersensitivity manifestations are very rare and of mild severity (1). The causative role of the drug in one case of allergic interstitial nephritis has been previously described (2). We have recently seen a patient who experienced bullous vasculitis, fever, and neutrophilia after therapy with diazepam.

Ms. A, a 50-year-old woman, was referred to our hospital for chronic depression or dysthymic disorder with alcohol dependence. There was no history of drug allergy. She was given 100 mg of thioridazine orally once a day and 10 mg of diazepam four times a day. After 2 days, she noticed an erythematous eruption on her ankles. Thioridazine treatment was first discontinued. As the eruption became more erythematous and affected both extremities and flanks within a few hours, methylprednisolone was administered at a dose of 80 mg daily. The next day, the eruption progressively became bullous, and Ms. A’s condition worsened. She felt ill and had pyrexia at 39.4˚C. Urea and creatinine levels stayed within normal limits. The results of blood cultures were negative. A skin biopsy revealed bullous vasculitis with numerous eosinophils within the dermis. Diazepam therapy was then discontinued, which led to the resolution of pyrexia and the progressive healing of the cutaneous lesions. Postinflammatory ulcers persisted on both ankles for 2 months. The results of a lymphocyte blast transformation test was positive for diazepam.

Cutaneous side effects of diazepam are very rare and of mild severity (1). To our knowledge, severe vasculitis from diazepam has not been previously reported. The imputability of the drug is strongly supported by the improvement of Ms. A’s condition after the discontinuation of diazepam and blastogenesis after in vitro exposure of her lymphocytes to the drug. We suggest that psychiatrists be aware of this potential side effect and allow prompt withdrawal of the drug.

References

1. Edwards JG: Adverse effects of antianxiety drugs. Drugs 1981; 22:494–514CrossrefGoogle Scholar

2. Sadjadi SA, McLaughlin K, Shah RM: Allergic interstitial nephritis due to diazepam. Arch Intern Med 1987; 147:579Crossref, MedlineGoogle Scholar